VEGF-D (vascular endothelial growth factor-D) monoclonal antibody and kit
A VEGF-D, monoclonal antibody technology, applied in the biological field, to achieve the effect of simple detection method, low cost, and good biological activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] 1. Preparation of VEGF-D antigen:
[0023] (1) Design a pair of primers according to the sequence of human VEGF-D (D89630.1) in the GenBank database. The upstream primer is vP: 5'-ATATGTACAGAGAGTGGGTAGTGGTGAATG-3', and the XhoI restriction site is introduced; the downstream primer is vP: 5' -TTAACAGCATGCTGCTTTGC-3', introduce EcoRI restriction site, extract total RNA from human hepatocytes by RT-PCR method, then reverse transcribe into cDNA, use cDNA as template, use Pyrobest DNA polymerase for VEGF-D gene specificity sexual amplification. The amplified PCR product was recovered from the gel, and the recovered VEGF-D gene and pPIC9K plasmid were respectively digested with Xho I and EcoR I, and the recovered target fragment was ligated with T4 ligase, and the ligated product was transformed into DH5α competent cells, passed through ampicillin (1 mg / mL) antibody screened positive clones, and the plasmids were extracted and identified by enzyme digestion and sequencing. ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



